

How does Brexafemme Kit work? Learn how Ibrexafungerp destroys yeast by targeting the fungal cell wall, explained in plain English with simple analogies.
If you've been prescribed Brexafemme Kit (Ibrexafungerp) for a vaginal yeast infection, you might be wondering how it actually works inside your body. The short answer: it attacks the "skeleton" of the yeast cell, causing it to collapse and die — without harming your own cells.
This guide breaks down Brexafemme Kit's mechanism of action in plain English, explains how quickly it works, and covers what makes it different from other yeast infection treatments.
Every living cell has a structure that holds it together. For yeast cells (like Candida, the fungus that causes vaginal yeast infections), a critical part of that structure is the cell wall. Think of the cell wall as the brick walls of a building — without them, the whole structure collapses.
The cell wall is made up of several components, and one of the most important is a substance called β-1,3-D-glucan (beta-glucan). This is essentially the "mortar" that holds the fungal cell wall together.
Brexafemme Kit contains the active ingredient Ibrexafungerp, which blocks an enzyme called glucan synthase. This enzyme is responsible for building the glucan that holds the cell wall together.
Here's a simple analogy: imagine a construction crew building a brick wall. Glucan synthase is the worker mixing and applying the mortar. Ibrexafungerp is like removing that worker from the job site. Without anyone to make the mortar, the wall can't be built — and existing walls start to weaken and crumble.
When Ibrexafungerp blocks glucan synthase:
Here's the clever part: human cells don't have cell walls. Our cells are held together by cell membranes, which are completely different structures. Since glucan synthase and β-1,3-D-glucan don't exist in human biology, Ibrexafungerp has a very specific target that only exists in fungi. This is why the drug can kill yeast without causing significant toxicity to your organs.
Brexafemme Kit starts working quickly. Here's what to expect:
If your symptoms don't improve within a week of completing treatment, contact your doctor. You may need additional evaluation or a different treatment approach. Check our alternatives guide for other options.
After taking Brexafemme Kit, the medication continues working even after you've finished the doses:
The one-day treatment approach works because Ibrexafungerp achieves high enough concentrations to effectively kill the Candida fungus before being naturally cleared by your body.
Fluconazole is the most commonly prescribed oral antifungal for yeast infections. It works by a completely different mechanism — it blocks an enzyme called lanosterol 14α-demethylase, which is needed to build the fungal cell membrane (not the cell wall). Think of it as targeting the paint on the building rather than the mortar.
Key differences:
Echinocandins are another class of antifungals that also target glucan synthase — the same enzyme that Brexafemme Kit blocks. However, there are important differences:
Oteseconazole is another newer medication for RVVC prevention. Key differences:
Having a first-in-class antifungal is significant for several reasons:
Brexafemme Kit works by blocking the construction of the yeast cell wall, causing fungal cells to weaken and die. Its unique mechanism — targeting glucan synthase at a site different from existing antifungals — makes it a valuable option for treating yeast infections, especially when other treatments haven't worked.
For more details about the medication, read our complete guide: What Is Brexafemme Kit? And if you're ready to fill a prescription, visit Medfinder to find it in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.